Curanex Pharmaceuticals Common Stock
CURX | NASDAQ
$5.20
+$0.04 (+0.78%)
Nov 2, 2026, 10:35 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
PE Ratio | -0.72 | -2.01 | -2.22 | -15.82 | -259.35 | -268 | -38.19M | -1.22B | -813.77 | -1.38Qu | -629.72Qu |
PEG Ratio | -0.16 | -0.87 | -0.01 | -0.01 | 4.61 | -661.96 | -1.03M | -9.63M | 18.09 | -2.62Q | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.57 | 1.79 | 0.83 | 1.43 | 365.24 | 304.98 | 221.62 | 174.16 | 155.97 | n/a | n/a |
P/FCF Ratio | -0.62 | -1.28 | -0.89 | -2.12 | -253.52 | -288.80 | n/a | n/a | -472.03 | n/a | n/a |
P/OCF Ratio | -0.62 | -1.28 | -0.89 | -2.12 | -253.52 | -288.80 | n/a | n/a | -472.03 | n/a | n/a |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.06 | 0.04 | 0.03 | 0 | 1.56 | 0.80 | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 45.95 | 62.87 | 81.93 | 77.53 | 9.37 | 3.61 | 35.54 | 102.04 | 1.11K | n/a | n/a |
Current Ratio | 45.95 | 62.87 | 81.93 | 77.53 | 9.37 | 3.61 | 35.54 | 102.04 | 1.11K | n/a | n/a |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | -232.60 | -18.65 | -101.37 | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -68.74% | -38.99% | -27.39% | -6.68% | -19.76% | -37.61% | -27.25% | -15.60% | -6.18% | n/a | n/a |
Return on Assets | -64.86% | -37.45% | -26.54% | -6.59% | -7.67% | -17.48% | -26.48% | -15.47% | -6.17% | n/a | n/a |
Return on Invested Capital | -65.67% | -37.94% | -26.74% | -6.63% | -7.37% | -20.92% | -27.53% | -15.94% | -6.18% | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove CURX